| Literature DB >> 31504652 |
Vuvi G Tran1, Arundhathi Venkatasubramaniam2, Rajan P Adhikari2, Subramaniam Krishnan2, Xing Wang1, Vien T M Le1, Hoan N Le1, Trang T T Vu1, Erika Schneider-Smith1, M Javad Aman2, Binh An Diep1.
Abstract
Staphylococcus aureus is a common pathogen causing infections in humans with various degrees of severity, with pneumonia being one of the most severe infections. In as much as staphylococcal pneumonia is a disease driven in large part by α-hemolysin (Hla) and Panton-Valentine leukocidin (PVL), we evaluated whether active immunization with attenuated forms of Hla (HlaH35L/H48L) alone, PVL components (LukS-PVT28F/K97A/S209A and LukF-PVK102A) alone, or combination of all 3 toxoids could prevent lethal challenge in a rabbit model of necrotizing pneumonia caused by the USA300 community-associated methicillin-resistant S. aureus (MRSA). Rabbits vaccinated with Hla toxoid alone or PVL components alone were only partially protected against lethal pneumonia, whereas those vaccinated with all 3 toxoids had 100% protection against lethality. Vaccine-mediated protection correlated with induction of polyclonal antibody response that neutralized not only α-hemolysin and PVL, but also other related toxins, produced by USA300 and other epidemic MRSA clones.Entities:
Keywords: MRSA; PVL; antibodies; pneumonia; vaccine; α-toxin
Mesh:
Substances:
Year: 2020 PMID: 31504652 PMCID: PMC6936001 DOI: 10.1093/infdis/jiz437
Source DB: PubMed Journal: J Infect Dis ISSN: 0022-1899 Impact factor: 5.226